Status:

COMPLETED

Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study

Lead Sponsor:

V.K.V. American Hospital, Istanbul

Conditions:

Colorectal Medullary Carcinoma

Eligibility:

All Genders

Brief Summary

Medullary carcinoma (MC) is a rare tumor with solid growth pattern without glandular differentiation and constitute less than 1% of colorectal cancer. Lymph node positivity and distant organ metastasi...

Detailed Description

427 patients with colorectal cancer who were underwent surgery between January 2011 and December 2017, were evaluated retrospectively into 2 groups as MC (n:13) and non-MC (n:414) in terms of demograp...

Eligibility Criteria

Inclusion

  • colorectal cancer diagnosis, medullary carcinoma

Exclusion

  • none

Key Trial Info

Start Date :

January 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2018

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT03774862

Start Date

January 1 2011

End Date

August 1 2018

Last Update

December 13 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study | DecenTrialz